{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/08/07/3341378/0/en/atyr-pharma-announces-second-quarter-2026-results-program-prioritization-and-corporate-restructuring-to-support-efzofitimod-program-in-ild.html", "message": "News view counter 870442 successfully enlarged"}